Concepts (215)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 36 | 2024 | 11118 | 2.060 |
Why?
|
| Oncogene Proteins, Fusion | 9 | 2023 | 1606 | 1.190 |
Why?
|
| Carcinoma, Renal Cell | 7 | 2024 | 3163 | 0.990 |
Why?
|
| Serine Endopeptidases | 7 | 2023 | 1021 | 0.870 |
Why?
|
| Kidney Neoplasms | 7 | 2024 | 4248 | 0.860 |
Why?
|
| Genetic Predisposition to Disease | 16 | 2024 | 17912 | 0.770 |
Why?
|
| Prostate-Specific Antigen | 4 | 2024 | 2469 | 0.650 |
Why?
|
| Trans-Activators | 4 | 2016 | 2856 | 0.650 |
Why?
|
| Molecular Epidemiology | 1 | 2021 | 469 | 0.630 |
Why?
|
| Antioxidants | 2 | 2017 | 1669 | 0.610 |
Why?
|
| Acrylamide | 1 | 2018 | 59 | 0.600 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2019 | 1115 | 0.520 |
Why?
|
| Nonsteroidal Anti-Androgens | 1 | 2015 | 9 | 0.500 |
Why?
|
| Diet Surveys | 1 | 2018 | 1162 | 0.460 |
Why?
|
| Genome-Wide Association Study | 12 | 2024 | 12688 | 0.450 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2023 | 12143 | 0.440 |
Why?
|
| Diet | 8 | 2023 | 8074 | 0.420 |
Why?
|
| Carotenoids | 1 | 2016 | 621 | 0.410 |
Why?
|
| Breast Neoplasms | 7 | 2023 | 21012 | 0.400 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2016 | 702 | 0.400 |
Why?
|
| Family Health | 1 | 2017 | 1257 | 0.390 |
Why?
|
| Risk Factors | 26 | 2024 | 74167 | 0.390 |
Why?
|
| Twins, Dizygotic | 3 | 2017 | 236 | 0.370 |
Why?
|
| Ferritins | 1 | 2014 | 597 | 0.370 |
Why?
|
| Follow-Up Studies | 17 | 2023 | 39117 | 0.350 |
Why?
|
| Prospective Studies | 19 | 2024 | 54415 | 0.340 |
Why?
|
| Twins, Monozygotic | 3 | 2017 | 470 | 0.340 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2023 | 3441 | 0.310 |
Why?
|
| Rectal Neoplasms | 1 | 2017 | 1157 | 0.300 |
Why?
|
| Dementia | 4 | 2023 | 2686 | 0.300 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2014 | 1355 | 0.280 |
Why?
|
| Male | 54 | 2024 | 360736 | 0.270 |
Why?
|
| Neoplasms | 10 | 2023 | 22164 | 0.240 |
Why?
|
| Polymorphism, Single Nucleotide | 13 | 2024 | 15941 | 0.240 |
Why?
|
| Incidence | 10 | 2023 | 21341 | 0.240 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 2538 | 0.240 |
Why?
|
| Middle Aged | 35 | 2024 | 220826 | 0.240 |
Why?
|
| Humans | 68 | 2024 | 761423 | 0.230 |
Why?
|
| Proportional Hazards Models | 9 | 2023 | 12456 | 0.220 |
Why?
|
| Aged | 32 | 2024 | 169235 | 0.220 |
Why?
|
| Obesity | 5 | 2024 | 12938 | 0.210 |
Why?
|
| Dementia, Vascular | 1 | 2023 | 122 | 0.200 |
Why?
|
| Multifactorial Inheritance | 2 | 2020 | 1392 | 0.200 |
Why?
|
| Body Mass Index | 6 | 2024 | 12951 | 0.200 |
Why?
|
| Lung Neoplasms | 3 | 2022 | 13337 | 0.200 |
Why?
|
| Alzheimer Disease | 4 | 2023 | 8596 | 0.180 |
Why?
|
| Membrane Proteins | 2 | 2017 | 7856 | 0.180 |
Why?
|
| Urologic Neoplasms | 1 | 2024 | 314 | 0.180 |
Why?
|
| Genetic Pleiotropy | 2 | 2020 | 181 | 0.170 |
Why?
|
| Cohort Studies | 9 | 2024 | 41446 | 0.170 |
Why?
|
| Hyperinsulinism | 1 | 2022 | 400 | 0.170 |
Why?
|
| Tea | 1 | 2021 | 288 | 0.160 |
Why?
|
| Prostate | 3 | 2023 | 1770 | 0.160 |
Why?
|
| Receptors, Somatomedin | 1 | 2018 | 56 | 0.160 |
Why?
|
| Case-Control Studies | 8 | 2020 | 22168 | 0.160 |
Why?
|
| Spouses | 1 | 2021 | 283 | 0.160 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2022 | 592 | 0.160 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 6935 | 0.150 |
Why?
|
| Adult | 19 | 2023 | 221148 | 0.150 |
Why?
|
| Immunohistochemistry | 5 | 2018 | 11073 | 0.140 |
Why?
|
| Coffee | 1 | 2021 | 593 | 0.130 |
Why?
|
| Walking | 1 | 2023 | 1200 | 0.130 |
Why?
|
| Female | 24 | 2024 | 392581 | 0.130 |
Why?
|
| Risk Assessment | 7 | 2020 | 23990 | 0.130 |
Why?
|
| Alopecia | 1 | 2020 | 411 | 0.130 |
Why?
|
| Exercise | 3 | 2023 | 5884 | 0.120 |
Why?
|
| Individuality | 1 | 2017 | 300 | 0.120 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1090 | 0.120 |
Why?
|
| Receptor, Insulin | 1 | 2018 | 835 | 0.120 |
Why?
|
| Disease Progression | 5 | 2024 | 13502 | 0.120 |
Why?
|
| Secondary Prevention | 1 | 2021 | 1474 | 0.120 |
Why?
|
| Health Behavior | 2 | 2023 | 2641 | 0.110 |
Why?
|
| GTPase-Activating Proteins | 1 | 2017 | 471 | 0.110 |
Why?
|
| Logistic Models | 2 | 2021 | 13255 | 0.110 |
Why?
|
| Life Style | 2 | 2022 | 3914 | 0.100 |
Why?
|
| Germ-Line Mutation | 1 | 2021 | 1858 | 0.100 |
Why?
|
| Particulate Matter | 1 | 2024 | 2595 | 0.100 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2015 | 410 | 0.100 |
Why?
|
| Plant Extracts | 1 | 2016 | 498 | 0.100 |
Why?
|
| Research Design | 2 | 2020 | 6178 | 0.100 |
Why?
|
| Odds Ratio | 4 | 2020 | 9645 | 0.100 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2016 | 621 | 0.100 |
Why?
|
| Killer Cells, Natural | 1 | 2021 | 2203 | 0.100 |
Why?
|
| Quantitative Trait Loci | 2 | 2017 | 2116 | 0.100 |
Why?
|
| Gene Frequency | 2 | 2017 | 3647 | 0.100 |
Why?
|
| Memory | 1 | 2021 | 2187 | 0.100 |
Why?
|
| Body Height | 1 | 2017 | 1570 | 0.090 |
Why?
|
| Gene Expression Profiling | 2 | 2024 | 9418 | 0.090 |
Why?
|
| Prostatectomy | 2 | 2023 | 1824 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2018 | 1931 | 0.090 |
Why?
|
| Meat | 1 | 2014 | 584 | 0.090 |
Why?
|
| Air Pollution | 1 | 2024 | 2348 | 0.090 |
Why?
|
| Congenital Abnormalities | 1 | 2015 | 709 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2023 | 9277 | 0.090 |
Why?
|
| Models, Statistical | 2 | 2015 | 5077 | 0.090 |
Why?
|
| Linkage Disequilibrium | 1 | 2015 | 2005 | 0.090 |
Why?
|
| Europe | 1 | 2017 | 3423 | 0.090 |
Why?
|
| Aged, 80 and over | 8 | 2021 | 58956 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 8545 | 0.080 |
Why?
|
| Receptors, Androgen | 1 | 2016 | 1079 | 0.080 |
Why?
|
| Premenopause | 1 | 2014 | 1039 | 0.080 |
Why?
|
| Gene Fusion | 1 | 2012 | 356 | 0.080 |
Why?
|
| Breast | 2 | 2017 | 1966 | 0.080 |
Why?
|
| Estradiol | 1 | 2016 | 1937 | 0.080 |
Why?
|
| Genotype | 2 | 2021 | 13009 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2273 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 3244 | 0.080 |
Why?
|
| Early Detection of Cancer | 2 | 2023 | 3201 | 0.080 |
Why?
|
| Colitis, Ulcerative | 1 | 2020 | 1922 | 0.070 |
Why?
|
| Cognition Disorders | 1 | 2022 | 3979 | 0.070 |
Why?
|
| Crohn Disease | 1 | 2020 | 2279 | 0.070 |
Why?
|
| Genetic Loci | 1 | 2017 | 2631 | 0.070 |
Why?
|
| Risk | 2 | 2016 | 9612 | 0.070 |
Why?
|
| Body Weight | 1 | 2017 | 4618 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2020 | 6238 | 0.070 |
Why?
|
| Aspirin | 1 | 2018 | 3134 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 2803 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2021 | 4650 | 0.060 |
Why?
|
| Testosterone | 1 | 2016 | 2472 | 0.060 |
Why?
|
| Quality of Life | 2 | 2023 | 13361 | 0.060 |
Why?
|
| Prognosis | 4 | 2018 | 29620 | 0.060 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2020 | 1008 | 0.060 |
Why?
|
| Smoking | 1 | 2021 | 9052 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2017 | 4936 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2016 | 3187 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 10194 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 4287 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2017 | 12330 | 0.050 |
Why?
|
| Mass Screening | 1 | 2018 | 5428 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2015 | 10089 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2023 | 314 | 0.050 |
Why?
|
| Retinoblastoma-Like Protein p107 | 1 | 2021 | 71 | 0.050 |
Why?
|
| Lung | 1 | 2020 | 9995 | 0.050 |
Why?
|
| Watchful Waiting | 1 | 2023 | 491 | 0.040 |
Why?
|
| United States | 5 | 2024 | 72339 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2022 | 8633 | 0.040 |
Why?
|
| Delayed Diagnosis | 1 | 2022 | 462 | 0.040 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2021 | 543 | 0.040 |
Why?
|
| Biological Specimen Banks | 1 | 2023 | 783 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2024 | 14599 | 0.040 |
Why?
|
| Interferons | 1 | 2021 | 705 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 15498 | 0.040 |
Why?
|
| Phenotype | 3 | 2022 | 16606 | 0.040 |
Why?
|
| Genes, BRCA1 | 1 | 2021 | 764 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2020 | 970 | 0.030 |
Why?
|
| Home Care Services | 1 | 2023 | 648 | 0.030 |
Why?
|
| Wnt Proteins | 1 | 2021 | 718 | 0.030 |
Why?
|
| Mammography | 2 | 2020 | 2430 | 0.030 |
Why?
|
| Neoplasm Staging | 3 | 2018 | 11106 | 0.030 |
Why?
|
| Exercise Therapy | 1 | 2023 | 928 | 0.030 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2018 | 379 | 0.030 |
Why?
|
| Insulin | 2 | 2022 | 6602 | 0.030 |
Why?
|
| Memory Disorders | 1 | 2023 | 1198 | 0.030 |
Why?
|
| beta Catenin | 1 | 2021 | 1040 | 0.030 |
Why?
|
| Educational Status | 1 | 2023 | 2520 | 0.030 |
Why?
|
| Androgens | 1 | 2023 | 1286 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2020 | 1682 | 0.030 |
Why?
|
| Young Adult | 2 | 2023 | 59207 | 0.030 |
Why?
|
| Alleles | 2 | 2017 | 6922 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2020 | 1812 | 0.030 |
Why?
|
| Infant | 1 | 2017 | 36205 | 0.030 |
Why?
|
| Finland | 1 | 2016 | 607 | 0.030 |
Why?
|
| Norway | 1 | 2016 | 498 | 0.030 |
Why?
|
| Aging | 2 | 2023 | 8705 | 0.030 |
Why?
|
| Endonucleases | 1 | 2017 | 371 | 0.030 |
Why?
|
| INDEL Mutation | 1 | 2015 | 266 | 0.030 |
Why?
|
| Androgen Antagonists | 1 | 2023 | 1410 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2017 | 42254 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2021 | 1742 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2021 | 1728 | 0.030 |
Why?
|
| Denmark | 1 | 2016 | 771 | 0.030 |
Why?
|
| Weight Gain | 1 | 2023 | 2347 | 0.030 |
Why?
|
| Executive Function | 1 | 2022 | 1389 | 0.030 |
Why?
|
| Adolescent | 2 | 2022 | 88313 | 0.030 |
Why?
|
| Sweden | 1 | 2016 | 1379 | 0.030 |
Why?
|
| Overweight | 1 | 2023 | 2413 | 0.030 |
Why?
|
| Genomics | 2 | 2020 | 5820 | 0.030 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2024 | 2223 | 0.020 |
Why?
|
| Biopsy | 1 | 2023 | 6766 | 0.020 |
Why?
|
| Survivors | 1 | 2022 | 2371 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 4912 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2021 | 5246 | 0.020 |
Why?
|
| Air Pollutants | 1 | 2024 | 2881 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2013 | 934 | 0.020 |
Why?
|
| Environmental Exposure | 1 | 2024 | 4467 | 0.020 |
Why?
|
| Smoking Cessation | 1 | 2021 | 2056 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 7045 | 0.020 |
Why?
|
| Child | 1 | 2017 | 80162 | 0.020 |
Why?
|
| Age Factors | 2 | 2015 | 18400 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2021 | 3414 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 8000 | 0.020 |
Why?
|
| Pedigree | 1 | 2015 | 4589 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2012 | 1125 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 20093 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 12058 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2021 | 23441 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2023 | 10203 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6479 | 0.020 |
Why?
|
| Postmenopause | 1 | 2014 | 2513 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 4124 | 0.010 |
Why?
|
| Gene Expression | 1 | 2017 | 7584 | 0.010 |
Why?
|
| Prevalence | 1 | 2020 | 15717 | 0.010 |
Why?
|
| Time Factors | 2 | 2016 | 39975 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2018 | 10441 | 0.010 |
Why?
|
| Apoptosis | 1 | 2018 | 9488 | 0.010 |
Why?
|
| Inflammation | 1 | 2022 | 10762 | 0.010 |
Why?
|
| Health Personnel | 1 | 2015 | 3335 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 5819 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 26112 | 0.010 |
Why?
|
| Registries | 1 | 2014 | 8223 | 0.010 |
Why?
|
| Physicians | 1 | 2015 | 4591 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 15262 | 0.010 |
Why?
|
| Brain | 1 | 2023 | 27107 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 36423 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2012 | 64651 | 0.000 |
Why?
|
Concepts
(215)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(33)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_